These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
910 related articles for article (PubMed ID: 21802369)
1. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369 [TBL] [Abstract][Full Text] [Related]
2. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070 [TBL] [Abstract][Full Text] [Related]
3. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369 [TBL] [Abstract][Full Text] [Related]
4. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152 [TBL] [Abstract][Full Text] [Related]
6. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features. Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156 [TBL] [Abstract][Full Text] [Related]
7. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease. Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834 [TBL] [Abstract][Full Text] [Related]
8. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging. Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153 [TBL] [Abstract][Full Text] [Related]
9. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease. Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939 [TBL] [Abstract][Full Text] [Related]
10. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review. Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963 [TBL] [Abstract][Full Text] [Related]
13. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes. Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165 [TBL] [Abstract][Full Text] [Related]
14. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease. Sabbagh MN; Malek-Ahmadi M; Dugger BN; Lee K; Sue LI; Serrano G; Walker DG; Davis K; Jacobson SA; Beach TG BMC Neurol; 2013 May; 13():44. PubMed ID: 23663404 [TBL] [Abstract][Full Text] [Related]
15. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study. Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
17. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy. Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361 [TBL] [Abstract][Full Text] [Related]
19. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43. Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Moloney CM; Labuzan SA; Crook JE; Siddiqui H; Castanedes-Casey M; Lachner C; Petersen RC; Duara R; Graff-Radford NR; Dickson DW; Mielke MM; Murray ME Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]